Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

Wednesday’s trading has closed, but MYL is being traded in the after-hours session. After-Hours quote »
50.54
Delayed Data
As of 4:00pm ET
 -0.20 / -0.39%
Today’s Change
37.59
Today|||52-Week Range
76.69
-6.53%
Year-to-Date

Today’s Trading

Previous close50.74
Today’s open51.21
Day’s range49.14 - 51.73
Volume11,127,117
Average volume (3 months)7,425,619
Market cap$25.0B
Dividend yield--
Data as of 4:00pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+21.77%
Earnings growth (next 5 years)+7.80%
Revenue growth (last year)+11.45%
P/E ratio21.8
Price/Sales2.89
Price/Book5.85

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-1.31-0.94%
VRXValeant Pharmaceutic...-0.99-1.14%
SHPGShire+2.71+1.79%
ZTSZoetis Inc-0.53-1.33%
Data as of 4:01pm ET, 02/10/2016

Financials

Next reporting dateFebruary 11, 2016
EPS forecast (this quarter)$1.28
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

Partner Offers